SCHW
40
3
PSX
24
2
HPE
48
2
GT
43
2
CNP
59
17
STZ
42
2
IP
53
3
OKE
61
2
KEY
24
2
EXR
42
5
MO
47
6
PNW
55
3
PEG
53
7
V
70
14
DNB
72
4
GME
61
2
DVA
62
5
HSY
32
3
PSA
43
6
IR
46
3
SCHW
40
3
PSX
24
2
HPE
48
2
GT
43
2
CNP
59
17
STZ
42
2
IP
53
3
OKE
61
2
KEY
24
2
EXR
42
5
MO
47
6
PNW
55
3
PEG
53
7
V
70
14
DNB
72
4
GME
61
2
DVA
62
5
HSY
32
3
PSA
43
6
IR
46
3
Financhill
Back

Integra Lifesciences Holdings 10K Form

Sell
22

IART
Integra Lifesciences Holdings

Last Price:
$21.79
Seasonality Move:
10.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-06 10Q IART/Integra Lifesciences Holdings Quarterly
2023-10-25 10Q IART/Integra Lifesciences Holdings Quarterly
2023-07-27 10Q IART/Integra Lifesciences Holdings Quarterly
2023-04-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-10-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-07-27 10Q IART/Integra Lifesciences Holdings Quarterly

Receive IART News And Ratings

See the #1 stock for the next 7 days that we like better than IART

IART Financial Statistics

Sales & Book Value

Annual Sales: $1.5B
Cash Flow: $-7.2M
Price / Cash Flow: 44.36
Annual Sales: $19.73
Price / Book: 1.11

Profitability

EPS (TTM): -0.09000
Net Income (TTM): $-6.5M
Gross Margin: $884.7M
Return on Equity: -0.42%
Return on Assets: -0.17%

Integra Lifesciences Holdings Earnings Forecast

Key Integra Lifesciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 29 years for IART is 57.39%.
  • The Selling, General & Administrative Expenses for IART have been equal to 42.60% of Gross Profit Margin.
  • The Research & Development expenses have been 6.76% of Revenue.
  • The Interest Expense is 75.84% of Operating Income.
  • The Net Earning history of IART is 4.39% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Integra Lifesciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: IART
CUSIP: 457985
Website: integralife.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 1.2
Quick Ratio: 0.58

Price-to-Earnings

Trailing P/E Ratio: 25.95
Forward P/E Ratio: 8.67

IART Technical Analysis vs Fundamental Analysis

Sell
22
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy or a Sell?